Nistala Kiran 4

What Happened
Nistala Kiran (role not specified in the filing) was granted a derivative equity award covering 340,900 shares of Zura Bio Ltd (ZURA) on April 1, 2026. The Form 4 reports the acquisition as an award (transaction code A) at $0.00 per share, so no cash changed hands and no sale or exercise was reported.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely filing).
• Type: Award/Grant of a derivative security (reported as 340,900 shares at $0.00).
• Shares owned following transaction: Not stated in the provided excerpt.
• Footnote (F1): Vesting — one-fourth vests on April 1, 2027, then one-twelfth of the remainder vests in equal quarterly installments thereafter, subject to continued service.
• No exercise or sale reported (this is a grant, not a purchase or disposition).

Context
The filing reflects a compensation grant (an option award per the footnote) that vests over time; it does not indicate an immediate purchase or sale by the insider. Grants like this are common for employee/executive compensation and primarily signal future potential ownership contingent on vesting and possible exercise terms.